Correlation between serum cyclophilin A and acute ST-segment elevation myocardial infarction and its predictive value

Correlation between serum cyclophilin A and acute ST-segment elevation myocardial infarction and its predictive value

ObjectiveAcute ST-segment elevation myocardial infarction (STEMI) is a serious cardiovascular event, and timely diagnosis and intervention are essential to improve prognosis. As a novel biomarker, serum cyclophilin A (CyPA) may play an important role in the development and progression of STEMI.Metho...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yuqi Wang, Long Wang, Caoyang Fang, Zhenfei Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-05-01
Series:	Frontiers in Cardiovascular Medicine
Subjects:	CyPA cyclophilin A STEMI ST-segment elevation myocardial infarction prediction
Online Access:	https://www.frontiersin.org/articles/10.3389/fcvm.2025.1566129/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Double Culprits in a Patient with ST Elevation Myocardial Infarction: A Challenging But Rewarding Case
by: Eka Ginanjar, et al.
Published: (2018-06-01)

Double Culprits in a Patient with ST Elevation Myocardial Infarction: A Challenging But Rewarding Case
by: Eka Ginanjar, et al.
Published: (2018-06-01)

Clinical features of the acute period of myocardial infarction with ST segment elevation in patients after reperfusion therapy
by: S. M. Kyselov, et al.
Published: (2020-10-01)

Annual personalised calculator for prognostication after ST-segment elevation myocardial infarction
by: V. B. Barbarich, et al.
Published: (2020-06-01)

Association of a Comprehensive ST‐Segment–Elevation Myocardial Infarction Protocol With Key Process Metrics Among Patients Transferred for Primary Percutaneous Coronary Intervention
by: Radoslav Zinoviev, et al.
Published: (2025-05-01)

ST-segment elevation myocardial infarction and the clinical significance of differentiated electrocardiogram
by: V. K. Tashchuk, et al.
Published: (2023-05-01)

Relationship of ST-segment elevation myocardial infarction with weather and season
by: Okkes Zortuk, et al.
Published: (2024-04-01)

LEFT VENTRICULAR REMODELING IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITH AND WITHOUT ST SEGMENT ELEVATION
by: N. E. Zakirova, et al.
Published: (2016-05-01)

The feasibility of Kimny guiding catheter for ST-segment elevation myocardial infarction
by: Sou-Chan Tsai, et al.
Published: (2022-01-01)

Correlation between coronary microvascular dysfunction and cardiorespiratory fitness in patients with ST-segment elevation myocardial infarction
by: Jinglin Li, et al.
Published: (2024-11-01)

Early Readmissions After ST‐Segment–Elevation Myocardial Infarction: Glass Ceiling or Room for Improvement?
by: Beau M. Hawkins, et al.
Published: (2018-09-01)

Association of cyclophilin A level and pulse pressure in predicting recurrence of cerebral infarction
by: Chen‐Shu Chang, et al.
Published: (2020-02-01)

Safety and Effectiveness of a Peripheral Rheolytic Thrombectomy Catheter in ST-Segment Elevation Myocardial Infarction: A Case Series
by: Giuseppe Giacchi, et al.
Published: (2025-02-01)

Relationship Between Infarct Artery, Myocardial Injury, and Outcomes After Primary Percutaneous Coronary Intervention in ST‐Segment–Elevation Myocardial Infarction
by: Suzanne de Waha, et al.
Published: (2024-09-01)

Reassess Hospital Costs and Mortality Between Myocardial Infarction With and Without ST‐Segment Elevation in a Modern Context
by: Honglan Ma, et al.
Published: (2024-11-01)

Short-term exposure to ambient air pollution increased in-hospital non-ST-elevation myocardial infarction mortality risk, but not ST-elevation myocardial infarction: case-crossover based evidence from Beijing, China
by: Yakun Zhao, et al.
Published: (2025-06-01)

In-hospital outcomes of ST elevation myocardial infarction in post-COVID-19 patients
by: M. G. Chashchin, et al.
Published: (2023-03-01)

<i>TRIM5α</i>/Cyclophilin A-Modified MDBK Cells for Lentiviral-Based Gene Editing
by: Lijing Wo, et al.
Published: (2025-06-01)

THE RELEVANCE OF THROMBOLYTIC THERAPY IN ST ELEVATION MYOCARDIAL INFARCTION
by: N. V. Teplova, et al.
Published: (2014-05-01)

THROMBOLYSIS OR PRIMARY PCI FOR MYOCARDIAL INFARCTION WITH ST-SEGMENT ELEVATION? THE STREAM TRIAL (STRATEGIC REPERFUSION EARLY AFTER MYOCARDIAL INFARCTION)
by: V. A. Sulimov
Published: (2015-09-01)

Association of Factor II G20210A, Factor V G1691A and methylenetetrahydrofolate reductase C677T gene polymorphism with different forms of myocardial infarction: ST segment elevation and non-ST segment elevation
by: Ćućuz-Jokić Milica, et al.
Published: (2020-01-01)

Predictors of health related quality of life three years after myocardial infarction with ST segment elevation
by: Lović Milan B.
Published: (2019-01-01)

Coronary Artery Lesions during Coronary Angiography in Acute ST-Segment Elevation Myocardial Infarction with and without Reciprocal Changes
by: Ibrahim Bilal Wahhab, et al.
Published: (2023-04-01)

Determination of the infarct‐related artery in patients with myocardial infarction without ST segment elevation
by: Sh. J. Khalilov
Published: (2024-04-01)

A Window of Opportunity: Leveraging Lung Ultrasound to Enhance Prognostication After ST‐Segment–Elevation Myocardial Infarction
by: Amer Abdulla, et al.
Published: (2024-11-01)

The prognostic and therapeutic significance of polyunsaturated fatty acid‐derived oxylipins in ST‐segment elevation myocardial infarction
by: Zhiyong Du, et al.
Published: (2025-02-01)

Effect of intramyocardial haemorrhage on structural and functional echocardiographic parameters of myocardium after ST-segment elevation myocardial infarction with
by: Ya. V. Alekseeva, et al.
Published: (2020-12-01)

Non-ST-elevation myocardial infarction: dual etiology, twoway therapy
by: Mihály Medvegy, et al.
Published: (2025-07-01)

PHARMACOEPIDEMIOLOGIC ANALYSIS OF ST-ELEVATION MYOCARDIAL INFARCTION REPERFUSION THERAPY AT SARATOV REGION HOSPITALS OF DIFFERENT TYPES
by: O. V. Reshetko, et al.
Published: (2016-01-01)

Short-Term Exposure to Air Pollution Associated with an Increased Risk of ST-Elevation and Non-ST-Elevation Myocardial Infarction Hospital Admissions: A Case-Crossover Study from Beijing (2013–2019), China
by: Yakun Zhao, et al.
Published: (2025-06-01)

Biventricular dysfunction predicts mortality in ST elevation myocardial infarction patients with cardiogenic shock
by: Angga Dwi Prasetyo, et al.
Published: (2025-01-01)

Genetic markers of risk for ST-elevated myocardial infarction
by: N. G. Lozhkina, et al.
Published: (2019-11-01)

Examining the Specificity of Smartphone ECG Devices in Decision-Making for ST-Elevation Myocardial Infarction and Non-ST-Elevation Myocardial Infarction
by: Sahil mahajan, et al.
Published: (2025-01-01)

Contemporary Trends and Age‐Specific Sex Differences in Management and Outcome for Patients With ST‐Segment Elevation Myocardial Infarction
by: Leonardo De Luca, et al.
Published: (2016-12-01)

EFFECTS OF CARVEDILOL ON PLATELET AGGREGATION IN MEN WITH ST-ELEVATION ACUTE MYOCARDIAL INFARCTION
by: A. N. Zakirova, et al.
Published: (2016-01-01)

Regressive Myocardial Infarction with ST Elevation (STEMI) Treated with Conservative Medicinal Therapy
by: Alexis Karaky, et al.
Published: (2019-08-01)

HATCH score associated with new-onset atrial fibrillation in patients with ST-segment elevation myocardial infarction
by: Shan Qin, et al.
Published: (2025-07-01)

Association of Circulating Phenylacetylglutamine With Multi‐Vessel Coronary Disease Severity and Outcomes in ST‐Segment–Elevation Myocardial Infarction
by: Peng Zhao, et al.
Published: (2025-02-01)

Prediction of in-hospital mortality in patients with ST-segment elevation acute myocardial infarction after percutaneous coronary intervention
by: B. I. Geltser, et al.
Published: (2023-07-01)

INSULIN RESISTANCE MARKERS IN PATIENTS WITH ST SEGMENT ELEVATION MYOCARDIAL INFARCTION
by: O. V. Gruzdeva, et al.
Published: (2011-12-01)